This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martín, J.
Right arrow Articles by Minor, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martín, J.
Right arrow Articles by Minor, P. D.

 Previous Article  |  Next Article 

Journal of Virology, April 2000, p. 3001-3010, Vol. 74, No. 7
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Evolution of the Sabin Strain of Type 3 Poliovirus in an Immunodeficient Patient during the Entire 637-Day Period of Virus Excretion

Javier Martín,* Glynis Dunn, Robin Hull, Varsha Patel, and Philip D. Minor

Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, United Kingdom

Received 4 October 1999/Accepted 21 December 1999

A 20-year-old female hypogammaglobulinemic patient received monotypic Sabin 3 vaccine in 1962. The patient excreted type 3 poliovirus for a period of 637 days without developing any symptoms of poliomyelitis, after which excretion appeared to have ceased spontaneously. The evolution of Sabin 3 throughout the entire period of virus excretion was studied by characterization of seven sequential isolates from the patient. The isolates were analyzed in terms of their antigenic properties, virulence, sensitivity for growth at high temperatures, and differences in nucleotide sequence from the Sabin type 3 vaccine. The isolates followed a main lineage of evolution with a rate of nucleotide substitution that was very similar to that estimated for wild-type poliovirus during person-to-person transmission. There was a delay in the appearance of antigenic variants compared to sequential type 3 isolates from healthy vaccines, which could be one of the possible explanations for the long-term excretion of virus from the patient. The distribution of mutations in the isolates identified regions of the virus possibly involved in adaptation for growth in the human gut and virus persistence. None of the isolates showed a full reversion of the attenuated and temperature-sensitive phenotypes of Sabin 3. Information of this sort will help in the assessment of the risk of spread of virulent polioviruses from long-term excretors and in the design of therapies to stop long-term excretion. This will make an important contribution to the decision-making process on when to stop vaccination once wild poliovirus has been eradicated.

* Corresponding author. Mailing address: Division of Virology, National Institute for Biological Standards and Control, Blanche Lane, Potters Bar, Hertfordshire EN6 3QG, United Kingdom. Phone: (44) 1707 654753. Fax: (44) 1707 646 730. E-mail: jmartin{at}nibsc.ac.uk.

Journal of Virology, April 2000, p. 3001-3010, Vol. 74, No. 7
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Savolainen-Kopra, C., Samoilovich, E., Kahelin, H., Hiekka, A.-K., Hovi, T., Roivainen, M. (2009). Comparison of poliovirus recombinants: accumulation of point mutations provides further advantages. J. Gen. Virol. 90: 1859-1868 [Abstract] [Full Text]  
  • Leitch, E. C. M., Bendig, J., Cabrerizo, M., Cardosa, J., Hyypia, T., Ivanova, O. E., Kelly, A., Kroes, A. C. M., Lukashev, A., MacAdam, A., McMinn, P., Roivainen, M., Trallero, G., Evans, D. J., Simmonds, P. (2009). Transmission Networks and Population Turnover of Echovirus 30. J. Virol. 83: 2109-2118 [Abstract] [Full Text]  
  • Odoom, J. K., Yunus, Z., Dunn, G., Minor, P. D., Martin, J. (2008). Changes in Population Dynamics during Long-Term Evolution of Sabin Type 1 Poliovirus in an Immunodeficient Patient. J. Virol. 82: 9179-9190 [Abstract] [Full Text]  
  • Riquet, F. B., Blanchard, C., Jegouic, S., Balanant, J., Guillot, S., Vibet, M.-A., Rakoto-Andrianarivelo, M., Delpeyroux, F. (2008). Impact of Exogenous Sequences on the Characteristics of an Epidemic Type 2 Recombinant Vaccine-Derived Poliovirus. J. Virol. 82: 8927-8932 [Abstract] [Full Text]  
  • Jorba, J., Campagnoli, R., De, L., Kew, O. (2008). Calibration of Multiple Poliovirus Molecular Clocks Covering an Extended Evolutionary Range. J. Virol. 82: 4429-4440 [Abstract] [Full Text]  
  • Lopez-Bueno, A., Segovia, J. C., Bueren, J. A., O'Sullivan, M. G., Wang, F., Tattersall, P., Almendral, J. M. (2008). Evolution to Pathogenicity of the Parvovirus Minute Virus of Mice in Immunodeficient Mice Involves Genetic Heterogeneity at the Capsid Domain That Determines Tropism. J. Virol. 82: 1195-1203 [Abstract] [Full Text]  
  • Dedepsidis, E., Kyriakopoulou, Z., Pliaka, V., Kottaridi, C., Bolanaki, E., Levidiotou-Stefanou, S., Komiotis, D., Markoulatos, P. (2007). Retrospective Characterization of a Vaccine-Derived Poliovirus Type 1 Isolate from Sewage in Greece. Appl. Environ. Microbiol. 73: 6697-6704 [Abstract] [Full Text]  
  • Labadie, K., Saulnier, A., Martin-Latil, S., Colbere-Garapin, F. (2007). Reduced Apoptosis in Human Intestinal Cells Cured of Persistent Poliovirus Infection. J. Virol. 81: 3033-3036 [Abstract] [Full Text]  
  • Kaiser, L., Aubert, J.-D., Pache, J.-C., Deffernez, C., Rochat, T., Garbino, J., Wunderli, W., Meylan, P., Yerly, S., Perrin, L., Letovanec, I., Nicod, L., Tapparel, C., Soccal, P. M. (2006). Chronic Rhinoviral Infection in Lung Transplant Recipients. Am. J. Respir. Crit. Care Med. 174: 1392-1399 [Abstract] [Full Text]  
  • Romanenkova, N. I., Guillot, S., Rozaeva, N. R., Crainic, R., Bichurina, M. A., Delpeyroux, F. (2006). Use of a Multiple Restriction Fragment Length Polymorphism Method for Detecting Vaccine-Derived Polioviruses in Clinical Samples. J. Clin. Microbiol. 44: 4077-4084 [Abstract] [Full Text]  
  • Burns, C. C., Shaw, J., Campagnoli, R., Jorba, J., Vincent, A., Quay, J., Kew, O. (2006). Modulation of Poliovirus Replicative Fitness in HeLa Cells by Deoptimization of Synonymous Codon Usage in the Capsid Region.. J. Virol. 80: 3259-3272 [Abstract] [Full Text]  
  • Yakovenko, M. L., Cherkasova, E. A., Rezapkin, G. V., Ivanova, O. E., Ivanov, A. P., Eremeeva, T. P., Baykova, O. Y., Chumakov, K. M., Agol, V. I. (2006). Antigenic Evolution of Vaccine-Derived Polioviruses: Changes in Individual Epitopes and Relative Stability of the Overall Immunological Properties. J. Virol. 80: 2641-2653 [Abstract] [Full Text]  
  • Simmonds, P., Welch, J. (2006). Frequency and Dynamics of Recombination within Different Species of Human Enteroviruses. J. Virol. 80: 483-493 [Abstract] [Full Text]  
  • Yang, C.-F., Chen, H.-Y., Jorba, J., Sun, H.-C., Yang, S.-J., Lee, H.-C., Huang, Y.-C., Lin, T.-Y., Chen, P.-J., Shimizu, H., Nishimura, Y., Utama, A., Pallansch, M., Miyamura, T., Kew, O., Yang, J.-Y. (2005). Intratypic Recombination among Lineages of Type 1 Vaccine-Derived Poliovirus Emerging during Chronic Infection of an Immunodeficient Patient. J. Virol. 79: 12623-12634 [Abstract] [Full Text]  
  • Rubio, M.-P., Lopez-Bueno, A., Almendral, J. M. (2005). Virulent Variants Emerging in Mice Infected with the Apathogenic Prototype Strain of the Parvovirus Minute Virus of Mice Exhibit a Capsid with Low Avidity for a Primary Receptor. J. Virol. 79: 11280-11290 [Abstract] [Full Text]  
  • Laassri, M., Dragunsky, E., Enterline, J., Eremeeva, T., Ivanova, O., Lottenbach, K., Belshe, R., Chumakov, K. (2005). Genomic Analysis of Vaccine-Derived Poliovirus Strains in Stool Specimens by Combination of Full-Length PCR and Oligonucleotide Microarray Hybridization. J. Clin. Microbiol. 43: 2886-2894 [Abstract] [Full Text]  
  • Minosse, C., Zaniratti, M. S., Calcaterra, S., Carletti, F., Muscillo, M., Pisciotta, M., Pillitteri, L., Corpolongo, A., Lauria, F. N., Narciso, P., Anzidei, G., Capobianchi, M. R. (2005). Application of a Molecular Panel To Demonstrate Enterotropic Virus Shedding by Healthy and Human Immunodeficiency Virus-Infected Patients. J. Clin. Microbiol. 43: 1979-1981 [Abstract] [Full Text]  
  • Cherkasova, E. A., Yakovenko, M. L., Rezapkin, G. V., Korotkova, E. A., Ivanova, O. E., Eremeeva, T. P., Krasnoproshina, L. I., Romanenkova, N. I., Rozaeva, N. R., Sirota, L., Agol, V. I., Chumakov, K. M. (2005). Spread of Vaccine-Derived Poliovirus from a Paralytic Case in an Immunodeficient Child: an Insight into the Natural Evolution of Oral Polio Vaccine. J. Virol. 79: 1062-1070 [Abstract] [Full Text]  
  • Shimizu, H., Thorley, B., Paladin, F. J., Brussen, K. A., Stambos, V., Yuen, L., Utama, A., Tano, Y., Arita, M., Yoshida, H., Yoneyama, T., Benegas, A., Roesel, S., Pallansch, M., Kew, O., Miyamura, T. (2004). Circulation of Type 1 Vaccine-Derived Poliovirus in the Philippines in 2001. J. Virol. 78: 13512-13521 [Abstract] [Full Text]  
  • Martin, J., Odoom, K., Tuite, G., Dunn, G., Hopewell, N., Cooper, G., Fitzharris, C., Butler, K., Hall, W. W., Minor, P. D. (2004). Long-Term Excretion of Vaccine-Derived Poliovirus by a Healthy Child. J. Virol. 78: 13839-13847 [Abstract] [Full Text]  
  • Kilpatrick, D. R., Ching, K., Iber, J., Campagnoli, R., Freeman, C. J., Mishrik, N., Liu, H.-M., Pallansch, M. A., Kew, O. M. (2004). Multiplex PCR Method for Identifying Recombinant Vaccine-Related Polioviruses. J. Clin. Microbiol. 42: 4313-4315 [Abstract] [Full Text]  
  • Salvati, A. L., De Dominicis, A., Tait, S., Canitano, A., Lahm, A., Fiore, L. (2004). Mechanism of Action at the Molecular Level of the Antiviral Drug 3(2H)-Isoflavene against Type 2 Poliovirus. Antimicrob. Agents Chemother. 48: 2233-2243 [Abstract] [Full Text]  
  • Blomqvist, S., Savolainen, C., Laine, P., Hirttio, P., Lamminsalo, E., Penttila, E., Joks, S., Roivainen, M., Hovi, T. (2004). Characterization of a Highly Evolved Vaccine-Derived Poliovirus Type 3 Isolated from Sewage in Estonia. J. Virol. 78: 4876-4883 [Abstract] [Full Text]  
  • Hovi, T., Lindholm, N., Savolainen, C., Stenvik, M., Burns, C. (2004). Evolution of wild-type 1 poliovirus in two healthy siblings excreting the virus over a period of 6 months. J. Gen. Virol. 85: 369-377 [Abstract] [Full Text]  
  • Korotkova, E. A., Park, R., Cherkasova, E. A., Lipskaya, G. Y., Chumakov, K. M., Feldman, E. V., Kew, O. M., Agol, V. I. (2003). Retrospective Analysis of a Local Cessation of Vaccination against Poliomyelitis: a Possible Scenario for the Future. J. Virol. 77: 12460-12465 [Abstract] [Full Text]  
  • Yang, C.-F., Naguib, T., Yang, S.-J., Nasr, E., Jorba, J., Ahmed, N., Campagnoli, R., van der Avoort, H., Shimizu, H., Yoneyama, T., Miyamura, T., Pallansch, M., Kew, O. (2003). Circulation of Endemic Type 2 Vaccine-Derived Poliovirus in Egypt from 1983 to 1993. J. Virol. 77: 8366-8377 [Abstract] [Full Text]  
  • Buttinelli, G., Donati, V., Fiore, S., Marturano, J., Plebani, A., Balestri, P., Soresina, A. R., Vivarelli, R., Delpeyroux, F., Martin, J., Fiore, L. (2003). Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis. J. Gen. Virol. 84: 1215-1221 [Abstract] [Full Text]  
  • Triki, H., Barbouche, M. R., Bahri, O., Bejaoui, M., Dellagi, K. (2003). Community-Acquired Poliovirus Infection in Children with Primary Immunodeficiencies in Tunisia. J. Clin. Microbiol. 41: 1203-1211 [Abstract] [Full Text]  
  • Minor, P D (2002). Eradication and cessation of programmes: Vaccination and public health care. Br Med Bull 62: 213-224 [Abstract] [Full Text]  
  • Cherkasova, E. A., Korotkova, E. A., Yakovenko, M. L., Ivanova, O. E., Eremeeva, T. P., Chumakov, K. M., Agol, V. I. (2002). Long-Term Circulation of Vaccine-Derived Poliovirus That Causes Paralytic Disease. J. Virol. 76: 6791-6799 [Abstract] [Full Text]  
  • Martin, J., Minor, P. D. (2002). Characterization of CHAT and Cox Type 1 Live-Attenuated Poliovirus Vaccine Strains. J. Virol. 76: 5339-5349 [Abstract] [Full Text]  
  • Liu, H.-M., Zheng, D.-P., Zhang, L.-B., Oberste, M. S., Pallansch, M. A., Kew, O. M. (2000). Molecular Evolution of a Type 1 Wild-Vaccine Poliovirus Recombinant during Widespread Circulation in China. J. Virol. 74: 11153-11161 [Abstract] [Full Text]  
  • Gavrilin, G. V., Cherkasova, E. A., Lipskaya, G. Y., Kew, O. M., Agol, V. I. (2000). Evolution of Circulating Wild Poliovirus and of Vaccine-Derived Poliovirus in an Immunodeficient Patient: a Unifying Model. J. Virol. 74: 7381-7390 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»